Enterprise League logo
SCYNEXIS, Inc. Logo

SCYNEXIS, Inc.

Jersey City, United States (US) · Health and Medical

Do you work at SCYNEXIS, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#drug development

#biotech

#infectious disease

#fungal disease

#rare disease

#adpkd

SCYNEXIS, Inc. is a Health and Medical company based in Jersey City, United States (US), founded in 2000, with 30-50 employees. SCYNEXIS, Inc.'s profile is verified on Enterprise League.

Overview

SCYNEXIS, Inc is a US-based biotechnology company specializing in the development of innovative therapies for severe, rare diseases.

We are dedicated to improving patient outcomes by targeting the underlying biology of these conditions, particularly focusing on unmet medical needs. Our core approach centers around developing highly differentiated, clinical-stage assets, including direct AMPK activators like SCY-770 and antifungal triterpenoids such as SCY-247.

SCYNEXIS is committed to advancing groundbreaking scientific breakthroughs that offer meaningful benefit to patients facing limited treatment options. Founded in 2000, we operate with a disciplined drug development execution and a focus on delivering impactful results. We are a public company (NASDAQ: SCYX) and are actively pursuing opportunities to transform the lives of individuals affected by rare diseases.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@scynexis.com

Jersey City, United States (US), 1 Evertrust Plaza

Founded

2000

Company Type

Public Limited Company

Employees

30-50

Categories

Biopharma
Life Science
Biotechnology

Keywords

#drug development

#biotech

#infectious disease

#fungal disease

#rare disease

#adpkd

Awards

• 2026 OpenSee all

Products

Default Product Image
SCY-247
Biotechnology

SCY-247 is a second-generation fungerp with enhanced pharmacological properties, developed for the treatment and prevention of severe and often fatal fungal diseases. It represents a significant advancement in combating antimicrobial resistance.

N/A

Companies teams usually look at after SCYNEXIS, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.